Endometrial Cancer Clinical Trials in Commack, New York

10 studies are recruiting for endometrial cancer in Commack, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

   This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Research Site, Commack, New York

   Locations

   67 in total

   Run by

   AstraZeneca

   See if you can join NCT05123482 on ClinicalTrials.gov

2. A Study of Ivonescimab in People With Endometrial and Cervical Cancers

   The researchers are doing this study to find out if ivonescimab is an effective treatment for people with endometrial cancer (EC) and/or cervical cancer (CC). The researchers will also look at whether the study drug is safe and causes few or mild side effects in participants.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack, New York

   Locations

   7 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT06925724 on ClinicalTrials.gov

3. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

   TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer Agents in Patients with Advanced/Metastatic Solid Tumours.

   Stage

   Phase 2

   Ages

   18 to 130

   Site

   Research Site, Commack, New York

   Locations

   96 in total

   Run by

   AstraZeneca

   See if you can join NCT05489211 on ClinicalTrials.gov

4. Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

   This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York

   Locations

   18 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT04291612 on ClinicalTrials.gov

5. A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

   The researchers are doing this study to find out whether elacestrant is an effective and safe treatment alone or in combination with abemaciclib for people with advanced or recurrent ER+ endometrial cancer.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Commack, Commack, New York

   Locations

   7 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT07209449 on ClinicalTrials.gov

6. ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

   The researchers are doing this study to evaluate the use of circulating tumor DNA (ctDNA) testing in making treatment decisions for advanced/recurrent endometrial cancer that has a change (mutation) in the mismatch repair deficient (MMR-D) gene or microsatellite instability high (MSI-H) gene. The r…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack, New York

   Locations

   7 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT07270666 on ClinicalTrials.gov

7. Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

   This study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial cancer who have recently undergone surgery.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York

   Locations

   7 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT04774419 on ClinicalTrials.gov

8. A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

   The purpose of this study is to find out whether short-course radiation therapy (1 week instead of the usual 5 weeks) with chemotherapy (carboplatin and paclitaxel) is practical (feasible), meaning that most participants are able to complete the treatment schedule.

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Commack (All protocol activities), Commack, New York

   Locations

   7 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT05691010 on ClinicalTrials.gov

9. A Study of a Weight Loss Intervention in People With Endometrial Cancer

   The researchers are doing this study is to find out whether tirzepatide and semaglutide are practical (feasible) for weight management and blood sugar control for endometrial cancer patients undergoing chemotherapy. The researchers will also look at participants' experience with the study drug, the…

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   Memorial Sloan Kettering Commack, Commack, New York

   Locations

   7 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT06751589 on ClinicalTrials.gov

10. A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer

    The researchers are doing this study to see how well multiparametric ultrasound (mpUS) imaging can evaluate vaginal tissue before and after IVRT. IVRT is routinely used to treat endometrial cancer but can cause damage to the vaginal tissue (vaginal toxicity). Side effects of vaginal toxicity can in…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack, New York

    Locations

    7 in total

    Run by

    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07318415 on ClinicalTrials.gov